Company Description Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come from
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office in
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office in
Salary Range:CHF169,400.00 - CHF314,600.00 Job Description SummaryIn this senior International CLS leadership role, you will help shape the global launch strategy for transformative treatment for blood cancers, driving impact across diverse markets and healthcare systems. Job
Senior Director, Medicine Development Leader Full-time Sobi Location: Germany Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and
Job Purpose The VP, Medical Affairs, Rare Diseases BU will provide strategic medical leadership and oversight to support the continued growth of the Rare Diseases (RRD) portfolio. S/he will champion patient centricity as key driver of
Summary Internal job title: Executive Director Location: Basel, Switzerland As the Head of Neurodegeneration within Translational Medicine, you will serve as a senior scientific and strategic leader responsible for shaping and delivering the translational strategy for
Medical Director – Multiple Sclerosis Lead and/or support early‑stage clinical projects for multiple sclerosis, translating innovative molecules into therapies to meet unmet medical needs. Design and execute clinical development plans from Phase1 through Phase2 (proof‑of‑concept). Provide